U.S. Capital Wealth Advisors, LLC Teva Pharmaceutical Industries LTD Transaction History

U.S. Capital Wealth Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 03, 2023	BUY	$7.95 - $9.48 $46,714 - $55,704	5,876 New	5,876 $53,000
Q1 2022 May 12, 2022	SELL	$7.33 - $9.39 $19,791 - $25,353	-2,700 Reduced 20.89%	10,226 $96,000
Q4 2021 Jan 21, 2022	SELL	$7.9 - $10.19 $922,214 - $1.19 Million	-116,736 Reduced 90.03%	12,926 $104,000
Q3 2021 Nov 01, 2021	BUY	$8.38 - $10.18 $1.09 Million - $1.32 Million	129,662 New	129,662 $1.26 Million

624

573M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of U.S. Capital Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on U.S. Capital Wealth Advisors, LLC with notifications on news.